Layer, Chiang, et al. Genome Biology
MDRNA Aims to Stay on Nasdaq Global Market, Arrowhead Shifts Shares to Capital Market
Both companies failed to meet the Nasdaq Global Market's minimum shareholder listing requirement. But while MDRNA aims to keep its shares remain on the exchange's top tier, Arrowhead instead requested its stock be moved to the Capital Market, where the listing requirements are less stringent.
New to GenomeWeb? Register here quickly.